{
  "ticker": "RCE",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02969180",
  "id": "02969180",
  "pages": 2,
  "price_sensitive": false,
  "date": "20250714",
  "time": "1810",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lsj85q39c8n0.pdf",
  "summary": "- **Capital Issuance**: Recce Pharmaceuticals Ltd (ASX:RCE) issued **811,062 new fully paid ordinary shares** under a cleansing notice (Section 708A(5)(e) of Corporations Act).  \n- **Disclosure Exemption**: Shares issued without Part 6D.2 disclosure.  \n- **Compliance Confirmed**: Company confirms compliance with Chapters 2M, 674, and 674A of Corporations Act (no excluded information).  \n\n**No material trading or capital markets impact identified beyond the share issuance**. Omitted operational/general company details as non-material to the announcement.",
  "usage": {
    "prompt_tokens": 935,
    "completion_tokens": 127,
    "total_tokens": 1062,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-14T09:17:00.008929"
}